PU 23 - ≥98%(HPLC) , CAS No.817635-93-1

CAS: 817635-93-1 Cat. No.: P287853 분자식: C₂₁H₁₉N₃O₃S₂ 분자량: 425.52 PubChem CID: 4779049

GRADE & PURITY ≥98%(HPLC)

Synonyms

N-[[[4-[[(페닐메틸)아미노]설포닐]페닐]아미노]티옥소메틸]벤즈아미드

Storage

20°C에서 보관

Shipped In

아이스 박스 + 아이스 패드

개요

제품 소개

다제내성 단백질(MRP) 4 억제제

Specifications

동의어

N-[[[4-[[(페닐메틸)아미노]설포닐]페닐]아미노]티옥소메틸]벤즈아미드

사양 및 순도

≥98%(HPLC)

생화학 및 생리적 메커니즘

다제내성 단백질(MRP) 4 억제제. MRP4 과발현 세포를 항암제6-메르캅토퓨린(6-MP)에 감작시킵니다(IC50값은 화합물이 없을 때와 있을 때 각각 14.11 및 6.06 μM입니다). 다음에서 6-MP의 축적을 증가시킵니다

보관 조건

20°C에서 보관

배송

아이스 박스 + 아이스 패드

작업 유형

INHIBITOR

순수함

≥98%(HPLC)

이름과 식별자

• Pubchem Sid: 504763128
• Pubchem Sid Url: https://pubchem.ncbi.nlm.nih.gov/substance/504763128
• 정식 스마일: C1=CC=C(C=C1)CNS(=O)(=O)C2=CC=C(C=C2)NC(=S)NC(=O)C3=CC=CC=C3
• IUPAC Name: N-[[4-(benzylsulfamoyl)phenyl]carbamothioyl]benzamide
• InChIKey: RYIRRFWVFHEXTH-UHFFFAOYSA-N
• INCHI: 1S/C21H19N3O3S2/c25-20(17-9-5-2-6-10-17)24-21(28)23-18-11-13-19(14-12-18)29(26,27)22-15-16-7-3-1-4-8-16/h1-14,22H,15H2,(H2,23,24,25,28)
• PubChem CID: 4779049
• 분자량: 425.52

화학 및 물리적 특성

• 용해성: Solvent:DMSO, Max Conc. mg/mL: 21.28, Max Conc. mM: 50

자주 묻는 질문

What is the purity of this product, and how is it determined?

This product is supplied at ≥98% purity, determined by HPLC. Lot-specific values are stated on the Certificate of Analysis.

How should this product be stored?

Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.

How is this product shipped?

This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.

What are the CAS number, molecular formula and molecular weight?

The CAS Number is 817635-93-1, the molecular formula is C21H19N3O3S2, and the molecular weight is 425.52 g/mol. InChIKey RYIRRFWVFHEXTH-UHFFFAOYSA-N.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.